170 related articles for article (PubMed ID: 38187300)
1. Newborn screening for fatty acid oxidation disorders in a southern Chinese population.
Lin Y; Lin C; Lin B; Zheng Z; Lin W; Chen Y; Chen D; Peng W
Heliyon; 2024 Jan; 10(1):e23671. PubMed ID: 38187300
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening.
Lin Y; Lin B; Chen Y; Zheng Z; Fu Q; Lin W; Zhang W
Orphanet J Rare Dis; 2021 Dec; 16(1):503. PubMed ID: 34863234
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
[TBL] [Abstract][Full Text] [Related]
4. Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency.
Lin Y; Zheng W; Chen Y; Huang C; Fu Q; Chen D; Peng W
Clin Chim Acta; 2022 Dec; 537():181-187. PubMed ID: 36334790
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China.
Lin Y; Zhang W; Chen Z; Lin C; Lin W; Fu Q; Peng W; Chen D
J Pediatr Endocrinol Metab; 2021 May; 34(5):649-652. PubMed ID: 33823107
[TBL] [Abstract][Full Text] [Related]
6. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
Wang S; Leng J; Diao C; Wang Y; Zheng R
J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China.
Chang S; Yang Y; Xu F; Ji W; Zhan X; Gao X; Chen T; Qiu W; Zhang H; Liang L; Lu D; Zhang K; Gu X; Han L
Front Genet; 2022; 13():1062715. PubMed ID: 36568374
[No Abstract] [Full Text] [Related]
8. [Newborn screening for primary carnitine deficiency and variant spectrum of SLC22A5 gene in Guangzhou].
Huang YL; Tang CF; Liu SC; Sheng HY; Tang F; Jiang X; Zheng RD; Mei HF; Liu L
Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):476-481. PubMed ID: 32521959
[No Abstract] [Full Text] [Related]
9. Increased detection of primary carnitine deficiency through second-tier newborn genetic screening.
Lin Y; Zhang W; Huang C; Lin C; Lin W; Peng W; Fu Q; Chen D
Orphanet J Rare Dis; 2021 Mar; 16(1):149. PubMed ID: 33757571
[TBL] [Abstract][Full Text] [Related]
10. Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China.
Yang X; Li Q; Wang F; Yan L; Zhuang D; Qiu H; Li H; Chen L
Front Genet; 2021; 12():686137. PubMed ID: 34249102
[TBL] [Abstract][Full Text] [Related]
11. Screening for newborn fatty acid oxidation disorders in Chongqing and the follow-up of confirmed children.
Chen M; Yin Y; Liu H; Peng Y; Ye L; Luo Q; Miao J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):290-297. PubMed ID: 36207828
[TBL] [Abstract][Full Text] [Related]
12. Screening 3.4 million newborns for primary carnitine deficiency in Zhejiang Province, China.
Lin Y; Xu H; Zhou D; Hu Z; Zhang C; Hu L; Zhang Y; Zhu L; Lu B; Zhang T; Huang X
Clin Chim Acta; 2020 Aug; 507():199-204. PubMed ID: 32371215
[TBL] [Abstract][Full Text] [Related]
13. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
[TBL] [Abstract][Full Text] [Related]
14. [Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up].
Zheng J; Zhang Y; Hong F; Yang J; Tong F; Mao H; Huang X; Zhou X; Yang R; Zhao Z; Huang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(3):248-255. PubMed ID: 29039165
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
[TBL] [Abstract][Full Text] [Related]
16. Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening.
Ji X; Ge Y; Ni Q; Xu S; Xiong Z; Yang L; Hu L; Cao Y; Lu Y; Wei Q; Kang W; Zhuang D; Zhou W; Dong X
Front Genet; 2023; 14():1304458. PubMed ID: 38125748
[TBL] [Abstract][Full Text] [Related]
17. Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China.
Zhou D; Cheng Y; Yin X; Miao H; Hu Z; Yang J; Zhang Y; Wu B; Huang X
Front Genet; 2022; 13():823687. PubMed ID: 35360862
[No Abstract] [Full Text] [Related]
18. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
19. Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.
Yang C; Shi C; Zhou C; Wan Q; Zhou Y; Chen X; Jin X; Huang C; Xu P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):472-480. PubMed ID: 34704412
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for primary carnitine deficiency using a second-tier genetic test.
Lin Y; Lin C; Zheng Z; Huang C; Peng W
J Pediatr Endocrinol Metab; 2024 Feb; 37(2):163-169. PubMed ID: 38158618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
